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Abstract
Full muscle relaxation happens when  [Ca2+] falls below the threshold for force activation. Several experimental models, 
from whole muscle organs and intact muscle down to skinned fibers, have been used to explore the cascade of kinetic events 
leading to mechanical relaxation. The use of single myofibrils together with fast solution switching techniques, has provided 
new information about the role of cross-bridge (CB) dissociation in the time course of isometric force decay. Myofibril’s 
relaxation is biphasic starting with a slow seemingly linear phase, with a rate constant, slow kREL, followed by a fast mono-
exponential phase. Sarcomeres remain isometric during the slow force decay that reflects CB detachment under isometric 
conditions while the final fast relaxation phase begins with a sudden give of few sarcomeres and is then dominated by 
intersarcomere dynamics. Based on a simple two-state model of the CB cycle, myofibril slow kREL represents the apparent 
forward rate with which CBs leave force generating states (gapp) under isometric conditions and correlates with the energy 
cost of tension generation (ATPase/tension ratio); in short slow kREL ~ gapp ~ tension cost. The validation of this relationship 
is obtained by simultaneously measuring maximal isometric force and ATP consumption in skinned myocardial strips that 
provide an unambiguous determination of the relation between contractile and energetic properties of the sarcomere. Thus, 
combining kinetic experiments in isolated myofibrils and mechanical and energetic measurements in multicellular cardiac 
strips, we are able to provide direct evidence for a positive linear correlation between myofibril isometric relaxation kinet-
ics (slow kREL) and the energy cost of force production both measured in preparations from the same cardiac sample. This 
correlation remains true among different types of muscles with different ATPase activities and also when CB kinetics are 
altered by cardiomyopathy-related mutations. Sarcomeric mutations associated to hypertrophic cardiomyopathy (HCM), 
a primary cardiac disorder caused by mutations in genes encoding sarcomeric proteins, have been often found to acceler-
ate CB turnover rate and increase the energy cost of myocardial contraction. Here we review data showing that faster CB 
detachment results in a proportional increase in the energetic cost of tension generation in heart samples from both HCM 
patients and mouse models of the disease.
Keywords Muscle mechanics · Muscle energetics · Cardiac muscle · Myofilaments · Myosin · Troponin · Hypertrophic 
cardiomyopathy
Introduction
The mechanical performance of cardiac muscle results 
from the interplay between two macromolecular systems: 
(1) membrane bound-calcium handling proteins, responsible 
for the  Ca2+ signal that starts and stops contraction; (2) sar-
comeric proteins, responsible for active and passive force 
generation and for contraction regulation by  Ca2+. To dis-
sect the relative roles of these two systems in the extent 
and kinetics of striated muscle contraction and relaxation, 
disparate preparations at all levels of the structural hierarchy 
have been used.
Though most models about the biochemical steps of 
crossbridge (CB) cycle and their regulation are based on 
studies of proteins in solution, isolated proteins lack the 
structural complexity and mechanical constraints of muscle 
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fibers. Myofibrils, formed by serially arranged sarcomeres, 
maintain a complete structured ensemble of contractile and 
 Ca2+ regulatory proteins. Thanks to the rapid equilibration 
with the medium, myofibrils allow the investigation of CB 
kinetic processes (for reviews see Poggesi et al. 2005; Stehle 
et al. 2009; Stehle and Tesi 2017). The possibility to easily 
obtain myofibrils from small human cardiac samples also 
provide a useful model to study disease-related mechanical 
and kinetic dysfunction in human cardiac sarcomeres (Nea-
goe et al. 2002; Piroddi et al. 2007, 2019; Belus et al. 2008, 
2010; Walker et al. 2011; Witjas-Paalberends et al. 2014a; 
Vikhorev et al. 2017; Jeong et al. 2018).
Familial hypertrophic cardiomyopathy (HCM) is the most 
common inherited heart disease with a prevalence of 1:500 
(Maron et al. 2014). It is considered a disease of the sar-
comere because several genes encoding cardiac myofilament 
proteins have been shown to cause the disease (Watkins et al. 
2011; Poggesi and Ho 2014). Some HCM-associated sar-
comeric mutations primarily result in aberrant/faster CB 
dynamics and increased ATP usage for the force generation 
process (Belus et al. 2008; Witjas-Paalberends et al. 2014a; 
Ferrantini et al. 2017; Piroddi et al. 2019). It has been sug-
gested long ago that sustained energy impairment in car-
diomyocytes may be central in HCM disease (Crilley et al. 
2003; Javadpour et al. 2003; Ashrafian et al. 2003).
Since the origin of the coupling between mechanic 
and energetic events during cardiac sarcomere contrac-
tion resides in the rates governing CB turn over, myofibril 
mechanic experiments associated with mechanic and ener-
getic experiments in skinned muscle strips, represent unique 
tools to dissect the physiology and pathophysiology of sar-
comere dynamics and energetics.
Myofibrils and fast solution switching: experimental 
tools to investigate apparent CB kinetics
While the complete cellular physiology of muscle contrac-
tion and relaxation can be only studied in intact muscle prep-
arations, dissecting the roles played by CBs and myofilament 
regulation in the kinetics of the twitch is obscured by the 
relatively slow rates of myoplasmic  Ca2+ rise and removal 
(Caputo et al. 1994; Gao et al. 1998; Bers 2001). To focus on 
the process of force generation and relaxation and its regula-
tion at the sarcomere level, skinned muscle preparations are 
to be employed. Indeed, the removal of all plasmatic and 
Sarcoplasmic Reticulum membranes allows investigators to 
experimentally control the  [Ca2+] in the surrounding solu-
tion and focus on the process of force generation and relaxa-
tion at myofilament level. Caged  Ca2+-compounds and caged 
 Ca2+-chelators can be used in skinned cardiac muscle prep-
arations to abruptly change the  [Ca2+] by flash photolysis 
and dissect the myofilament mechanisms of force activation 
and force relaxation from those related to myoplasmic  Ca2+ 
handling (e.g. Palmer and Kentish 1998). The use of caged 
compounds, however, is not free from problems. Caged com-
pounds have general inherent limitations with respect to the 
input of large radiant energies and the production of reactive 
photolytic by‐products as well as uncertainties in the actual 
concentration of the compounds inside the skinned muscle 
preparations. Moreover, the kinetics of force activation and 
relaxation require different caged compounds and must be 
studied separately (see Palmer and Kentish 1998). If we want 
to focus on the relaxation process one significant additional 
limit of caged compounds is that the increased  Ca2+ buffer-
ing capacity following photolysis of caged  Ca2+-chelators is 
not enough to induce a complete relaxation from high levels 
of activation (Wahr et al. 1998; Luo et al. 2002).
Isolated myofibrils, as a model for mechanical experi-
ments, hold some advantages over larger preparations and 
are ideal to obtain insight about the CB kinetics during an 
activation-relaxation cycle (e.g. Poggesi et al. 2005). Iso-
lated myofibrils are the smallest subdivision of the contrac-
tile apparatus of striated muscle that retain the organized 
filament lattice and entire ensemble of associated proteins. 
Because of their small size (the diffusion distances are 
< 2 µm), rapid (< 1 ms) equilibration is ensured with sur-
rounding solution and thus, the myofilament lattice can be 
effectively clamped at any desired composition by flowing 
streams of solution over the preparation. Rapid solution 
switching methods in myofibrils have given straightforward 
insights into the kinetics of force activation and relaxation 
following abrupt increase and decrease of  [Ca2+] (for a 
review see Stehle et al. 2009).
The abrupt rise of  [Ca2+] by fast solution switching in 
human and mouse ventricular myofibrils at optimum over-
lap (see Fig. 1A, B) initiates tension development processes 
that are qualitatively similar but with much different rates. 
At maximal  Ca2+ activation, tension rises approximately 
mono-exponentially, with a rate constant kACT  that is one 
order of magnitude faster in the mouse ventricular myofibril 
compared to the human preparation (Fig. 1C). Under steady-
state conditions of force generation a large mechanical per-
turbation is applied to the myofibrils aimed at detaching 
most of the attached force generating CBs (Fig. 1A, B). This 
mechanical perturbation drops force to zero before starting 
a force redevelopment process, with rate kTR, that is thought 
to reflect the apparent CB turnover rate under conditions 
of steady-state activation (Brenner 1988). Under our usual 
experimental conditions, kACT  is the same as kTR, indicat-
ing that thin filament  Ca2+-activation is a rapid process and 
that both kinetic parameters reflect the apparent rate of CB 
turn-over.
Full force relaxation of human and mouse ventricular 
myofibrils, induced by rapid reduction in  [Ca2+] below con-
tractile threshold, is markedly biphasic (Fig. 1D), like in all 
myofibril types studied so far. The behaviour parallels that 
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previously described in intact skeletal muscle fibres relaxing 
from maximum tetanic force (Huxley and Simmons 1970, 
1973; Cleworth and Edman 1972; Edman and Flitney 1982). 
Force relaxation starts with a slow, seemingly linear, phase 
with a rate constant slow kREL that is thought to reflect the 
apparent rate of CB detachment under isometric conditions 
also because in myofibril experiments the bulk of the slow 
relaxation phase occurs after  [Ca2+] has been effectively 
reduced below contractile threshold (Poggesi et al. 2005). 
The slow force decay is followed by a rapid and exponential 
decay of force, with a rate constant fast kREL. While myofi-
bril sarcomeres remain isometric during the early slow 
relaxation phase, the final fast force decay is initiated when 
a few, mechanically weaker, sarcomeres rapidly lengthen 
(sarcomere “give”) and is then dominated by inter-sarcomere 
dynamics (Stehle et al. 2002; Poggesi et al. 2005). Overall 
force relaxation is much faster in the mouse compared to the 
human preparation (Fig. 1D).
Previous studies in myofibrils have shown that CBs are 
the major determinants of the kinetics of tension activation 
and of the early isometric phase of relaxation whereas the 
regulatory  Ca2+ switch is a much faster process (Poggesi 
et al. 2005; Stehle et al. 2009). Some of the evidence col-
lected during the last years in favour of the dominant role of 
CBs in myofibril tension kinetics are listed below.
 (i) Under the conditions of our myofibril experiments 
(maximal  Ca2+-activation, sarcomere length 2.20 µm, 
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Fig. 1  Tension activation and relaxation of mouse and human ven-
tricular myofibrils. A, B Top traces, representative tension records 
of mouse (A) and human (B) ventricular myofibrils maximally 
 Ca2+-activated and fully relaxed by fast solution-switching (15  °C). 
Resting sarcomere length 2.2  μm. The arrows mark the start of the 
solution changes that modify the myofibril pCa as indicated. Bot-
tom traces are length signals showing the release-restretch protocol 
applied to the myofibrils under conditions of steady  Ca2+-activation. 
kACT  is the rate constant of tension development following maximal 
 Ca2+ activation; kTR is the rate constant of tension redevelopment fol-
lowing release-restreach protocol during steady-state  Ca2+ activation. 
C, D Same traces as in A, B superimposed on a faster time base after 
normalization for maximal tension to highlight force activation (C) 
and relaxation (D) kinetics. As shown in D full tension relaxation 
from maximal activation is biphasic both in mouse and human myofi-
brils. The rate constant of the early slow force decline (slow kREL) is 
estimated from the slope of the regression line fitted to the force trace 
normalized to the entire amplitude of the force relaxation transient. 
The rate constant for the final fast phase of tension decline (fast kREL) 
is estimated from mono-exponential fit. Of note, both the kinetics of 
force activation (C) and force relaxation (D) are much faster in the 
mouse compared to the human ventricular myofibril indicating faster 
cross-bridge turnover and faster detachment rate respectively
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low  [Pi], relatively low temperature 5–15 °C) kACT  
and kTR are essentially identical in a variety of prepa-
rations that largely differ in tension kinetics (Fig. 2). 
As already mentioned above, kTR is measured under 
quasi-steady state conditions of thin filament activa-
tion and is thought to reflect CB turnover; kACT  could 
in principle be a slower process as it may also be 
limited by thin filament activation kinetics. As shown 
in Fig. 2, kACT  never falls below the identity line with 
kTR strongly suggesting that both parameters primar-
ily reflect CB turnover rate whereas  Ca2+-activation 
is a much faster process.
 (ii) The lack of a significant influence of thin filament 
activation/inactivation kinetics on myofibril ten-
sion activation and relaxation kinetics was also clear 
from the comparison between fluorescence stopped 
flow studies on cardiac myofibril suspensions and 
mechanical studies on single cardiac myofibrils. The 
results (Solzin et al. 2007 reviewed by Stehle et al. 
2009) showed that the structural changes in cardiac 
Troponin (Tn) following calcium binding to or dis-
sociation from cardiac TnC in response to sudden 
increase or decrease in calcium (Tn switch) are much 
faster than myofibril force activation and relaxation 
kinetics.
 (iii) Tn replacement studies in myofibrils further support 
the idea that contraction-relaxation myofibril kinet-
ics, following abrupt increase/decrease in  [Ca2+], are 
mainly set by the intrinsic CB cycling rate and are 
not directly altered by the kinetics of the Tn switch 
(Piroddi et al. 2003; de Tombe and Stienen 2007). 
Notably, as shown in Fig. 1 and Table 1, the kinetics 
of force activation and relaxation in mouse ventricu-
lar myofibrils are almost tenfold faster than in human 
ventricular myofibrils. However, exchange of human 
cardiac Tn for the endogenous mouse cardiac Tn in 
mouse ventricular myofibrils does not slow down 
force kinetics (see Table 1) indicating that it is the 
myosin motor form that sets the force kinetics of car-
diac sarcomeres. Studies of replacement of all thin 
filament regulatory proteins (Tn and Tropomyosin) in 
myofibrils confirm the idea of a dominant role of CB 
cycling rate in determining the kinetics of sarcomere 
tension activation and relaxation (Siththanandan 
et al. 2009; Scellini et al. 2010).
 (iv) Changes in the concentrations of substrate and prod-
ucts of the acto-myosin ATPase markedly affect 
myofibril force activation and relaxation kinetics 
(Tesi et al. 2002). For instance, inorganic phosphate 
accelerates force kinetics in cardiac myofibrils; 
in particular it increases the rate of the slow force 
decay, consistent with the idea that slow kREL reflects 
the dissociation of force generating CBs to non-
force-generating states via both forward and back-
ward transitions (Stehle and Tesi 2017). At variance 
with the large impact of interventions that interfere 
with key CB transitions, interventions that increase 
myofilament  Ca2+-sensitivity by altering the  Ca2+ 
Tn switch usually do not significantly affect kACT , 
kTR, and slow kREL measured in cardiac myofibrils at 
maximal activation (Piroddi et al. 2007; Kreutziger 
et al. 2011).
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Fig. 2  Rates of tension activation and tension redevelopment in dif-
ferent types of maximally  Ca2+-activated skeletal and cardiac myofi-
bril preparations at 5 or 15  °C. Mean ± SEM (n ≥ 11). Dotted line, 
identity line. Unpublished data
Table 1  Kinetic parameters of mouse and human ventricular myofibrils following replacement by exchange of the endogenous cTn complex 
with human recombinant cTn
Data are mean ± SEM; n ≥ 10. Data from human cTn exchanged mouse myofibrils and control (sham-treated) mouse myofibrils are unpublished 
data; data from human cTn exchanged human ventricular myofibrils are from Piroddi et al. (2019). The exchange protocol allows replacement of 
70–90% of the endogenous cTn complex
Myofibril type kACT   (s−1) kTR  (s−1) Slow kREL  (s−1) Fast kREL  (s−1)
Mouse Ventr (control) 7.35 ± 0.54 7.12 ± 0.61 1.45 ± 0.21 28.3 ± 2.9
Mouse Ventr (human cTn exchanged) 7.05 ± 0.44 6.92 ± 0.75 1.55 ± 0.28 25.3 ± 3.1
Human Ventr (human cTn exchanged) 0.84 ± 0.03 0.78 ± 0.04 0.30 ± 0.02 4.65 ± 0.19
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To better interpret myofibril tension kinetic parameters in 
terms of apparent CB kinetics we need a description of the 
reaction pathway for acto-myosin ATPase and energy-trans-
duction cycle. The reaction pathway is usually described as 
a series of coupled biochemical and mechanical events with 
a relatively large number of transitions (Gordon et al. 2000; 
see also Fig. 5 in Ferrantini et al. 2009). Generally accepted 
schemes can be reduced for our purposes to a simpler two-
state CB scheme (Brenner 1988). On the basis of myosin’s 
binding affinity for actin, two general types of CBs can be 
defined in the two-state model of acto-myosin interactions: 
 AMno force that represents all detached and “weak binding 
states” (detached states M.ATP, M.ATP.Pi in rapid equi-
librium with AM.ATP, AM.ADP.Pi) and  AMforce that rep-
resents all “strong binding states” (AM, AM*.ADP). The 
exoergonic release of inorganic phosphate  (Pi) is thought 
to power the working stroke. The transition from the non-
force-generating states to the force generating states has an 
overall apparent rate constant fapp. It is well known that at 
physiological  [Pi] the power stroke reverse transition may 
occur so that the return to the non force generating states 
may occur both through the backward transition  (Pi rebind-
ing and reversal of the power stroke) and the forward tran-
sition (ADP release and ATP binding). The apparent rate 
constant for the forward transition is gapp while the apparent 
rate constant for the reverse transition of the force generating 
step is f′app that depends on [Pi].
In the virtual absence of  Pi, that is the experimental con-
dition of most myofibril studies, the apparent rate constant 
for the reverse transition f′app can be neglected. Thus, dur-
ing myofibril relaxation, following  Ca2+ removal, strongly 
bound CBs can leave the force-generating states only via 
forward transitions whereas weakly-bound CBs are unable 
to go into the force-generating states (Poggesi et al. 2005; 
Ferrantini et al. 2009). In terms of CB turnover kinetics, 
myofibril slow kREL measured in the absence of  Pi consists 
solely of forward CB detachment, that leads to ATP hydroly-
sis steps, continuing at the same rate as during the isometric 
contraction; in short slow kREL ~ gapp.
According to this model, the overall CB turnover rate, 
given by fapp + gapp, is reflected by kACT  and kTR, maximal 
tension is proportional to fapp/(fapp + gapp), ATPase activity 
is proportional to f app · gapp/(fapp + gapp), and the energy cost 
of tension generation (ATPase/tension ratio) is proportional 
to gapp (Brenner, 1988; de Tombe and Stienen 2007). Given 
slow kREL ≈ gapp, an increase/decrease in slow kREL should 
be able to predict an increase/decrease in the amount of ATP 
spent to generate a given amount of isometric force (i.e. the 
energy cost of tension generation).
AM
NoForce
fapp
−−→
←−−
f �
app
AM
Force
gapp
→ AM
NoForce
Direct and coupled measurements of isometric tension 
and ATPase activity under isometric conditions can une-
quivocally confirm this conclusion.
Cardiac sarcomere energetics and the correlation 
between energy cost of tension generation 
and the isometric relaxation rate of cardiac 
myofibrils from different preparations
Chemically permeabilized cardiac muscle strips, isolated 
from human and animal hearts, are the conventional prepa-
rations used to measure the isometric rate of ATP consump-
tion of the sarcomeric proteins and to directly correlate the 
amount of ATP hydrolyzed to the amount of developed force 
(i.e. the tension cost of cardiac contraction) (de Tombe and 
Stienen 1995, 2007; Narolska et al. 2005; Witjas-Paalber-
ends et al. 2014a, b). The removal of virtually all mem-
brane structures leaves the sarcomeric proteins (i.e. myosin 
motors) as the only source of energy consumption in these 
preparations and this allows us to circumvent many of the 
problems that hamper myothermal measurements on intact 
myocardium (Holubarsch et al. 1991; Alpert et al. 1991; de 
Tombe and Stienen 2007). Indeed, interpretation of myo-
thermal experiments in intact preparations can be mainly 
complicated by uncertainties in the relative amount of total 
energy that is used by the excitation contraction coupling 
system or by the sarcomeric proteins (Gibbs et al. 1988). 
It is to be noted, however, that in recent myothermal stud-
ies the use of blebbistatin, that selectively inhibits myosin 
activity, has allowed more accurate estimate of the energy 
expenditure associated with  Ca2+ handling in intact cardiac 
muscle (Pham et al. 2017).
One of the main advantages of skinned preparations is 
that they allow standardization of the experimental condi-
tions (e.g. composition of the intracellular medium, level 
of  Ca2+-activation), thus minimizing disturbing factors pre-
sent during the normal twitch of intact cardiac muscle (i.e. 
variable calcium concentration, hormonal factors, concen-
trations of metabolic products) (van der Velden et al. 1998; 
Narolska et al. 2005). The simultaneous measurement of iso-
metric force and ATPase activity in skinned cardiac strips, 
by means of an enzymatic coupled assay, allows a direct 
correlation between mechanic and energetic properties of 
cardiac sarcomeres.
In this method, the re-synthesis of ATP, catalyzed by 
pyruvate kinase, is enzymatically coupled to the oxidation 
of nicotinamide dinucleotide (NADH), catalyzed by lactate 
dehydrogenase. The breakdown of NADH can be deter-
mined photometrically by measuring the absorbance of 340-
nm near-UV light (Glyn and Sleep 1985; Stienen et al. 1993; 
Kentish and Stienen 1994; Potma et al. 1994; de Tombe 
and Stienen 1995, 2007). As shown in Fig. 3, simultaneous 
measurements of maximal isometric tension and ATPase 
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activity in mouse and human ventricular strips at optimum 
overlap demonstrate that the slope of the NADH absorbance 
signal during steady activation is markedly higher in the 
mouse versus the human preparation. The difference in the 
amount of maximal tension developed by the two prepara-
tions is not enough to account for the higher ATPase found 
in the mouse myocardium. This indicates that tension cost 
is much greater in the mouse sarcomeres.
By combining mechanical experiment on single myofi-
brils (Fig. 1) and simultaneous mechanic and energetic 
experiments on larger skinned muscle preparations (Fig. 3) 
one can directly investigate the relation between CB turnover 
rate and ATP utilization during isometric muscle contrac-
tion. We found that, in disparate types of striated muscles 
from different species, the slow kREL measured in myofibrils 
in our laboratory significantly correlated with the respective 
energy cost of isometric tension generation measured by dif-
ferent laboratories in skinned preparations from the same 
muscle type (Fig. 4). In spite of the difference in tempera-
ture between the experiments in myofibrils and multicellu-
lar skinned preparations and the potential differences in the 
experimental conditions used in the different laboratories 
where the energetic measurements were taken the correla-
tion is rather good. Tension cost data in Fig. 4 are from 
Narolska et al. (2005) (human atrial and ventricular muscle), 
from Joumaa et al. (2017) (rabbit psoas), from Ferrantini 
et al. (2017) (mouse ventricle), and from unpublished data 
from our laboratory for mouse atrial muscle.
The correlation in Fig. 4 is strong evidence in support of 
the idea that slow kREL ≈ gapp ≈ tension cost. Of note, the pos-
itive correlation between these two parameters holds true for 
muscle types that greatly differ in their actomyosin ATPase 
rate. In human myocardium, the slow β Myosin Heavy Chain 
(β-MHC) isoform is predominantly expressed in the ventri-
cles whereas the fast α-MHC isoform is the main molecular 
motor of the atria. Previous studies on rat and rabbit sam-
ples had shown that the fast α-MHC isoform exhibits a two 
to three times higher actin-activated ATPase activity (Pope 
et al. 1980) and actin filament sliding velocity than the slow 
β-MHC isoform (Harris et al. 1994). We also had previously 
found that the much faster relaxation kinetics of atrial vs 
ventricular myofibrils are consistent with the large difference 
in CB kinetics between the two MHC isoforms (Piroddi et al. 
2007). The proportionality between CB kinetics and tension 
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Fig. 3  Simoultaneous measurements of isometric tension and ATPase 
activity in permeabilized mouse and human ventricular strips. Repre-
sentative traces of force (top) and ATPase activity (bottom) from per-
meabilized mouse (A) and human (B) ventricular strips at maximal 
 Ca2+-activation. The muscle strips were activated in saturating  [Ca2+] 
solution (pCa 4.5). Isometric force started to develop and NADH 
absorbance signal started to decline. After force and the slope of the 
absorbance signal had reached a steady level the muscle strips were 
relaxed in a low  [Ca2+] solution (pCa10). The rate of ATP consump-
tion was determined from the slope of the NADH absorbance signal 
during the last 20 s of activation. Notably, the slope is much steeper 
in mouse ventricle strip (A) than in human preparation (B), indica-
tive of a greater ATP consumption to develop force. Sarcomere length 
2.2 µm. Temperature: 20 °C
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cost is maintained, since direct measurements of ATPase 
activity confirm that a ~ fourfold higher slow kREL (Piroddi 
et al. 2007) corresponds to a ~ fivefold higher tension cost 
in atrial vs ventricular human myocardium (Narolska et al. 
2005). At variance with human myocardium, in rodents’ 
heart α-MHC is the main myosin isoform expressed both in 
the atria and in the ventricles. Of note, as shown in Fig. 4, 
the kinetics of the slow phase of relaxation and tension cost 
are rather similar between preparations from the two cardiac 
chambers of the mouse.
Cardiomyopathy‑related alterations of CB kinetics 
and energetics: increased slow relaxation kinetics 
underlie higher tension cost
Myofibril kinetics and energetics have been shown to be 
altered by several sarcomeric protein mutations associated 
to genetic cardiomyopathies. In particular, HCM is a genetic 
disease primarily caused by mutations in the genes encoding 
sarcomeric proteins (e.g. for reviews see Watkins et al. 2011; 
Poggesi and Ho 2014). To date, it is unclear how these muta-
tions lead to the cardiac phenotype also because patients 
carrying the same causal mutation may exhibit different 
clinical phenotypes.
With the exception of truncation mutations in cardiac 
myosin binding protein C for which evidence of haploin-
sufficiency has been generated (Marston et al. 2009; van 
Dijk et al. 2009), most HCM mutations result in stable 
proteins that are incorporated into the sarcomere and may 
act as poison peptides on the contractile performance, (e.g. 
Cuda et al. 1993; Bottinelli et al. 1998). In vitro studies 
on human and animal HCM muscle preparations and iso-
lated proteins suggested that the pathogenic impact of the 
mutations can be attributed to different mechanisms such 
as: aberrant CB dynamics leading to decreased/increased 
contractility, (e.g. Cuda et al. 1993; Palmiter et al. 2000; 
Belus et al. 2008; Palmer et al. 2008; Witjas-Paalberends 
et al. 2014a), increased intrinsic force of the myosin motor 
(Seebohm et al. 2009; Sommese et al. 2013), increased sar-
comeric  Ca2+ sensitivity, e.g. (Bottinelli et al. 1998, for a 
review see Marston 2011). To reconcile the lack of consist-
ent contractility changes in HCM, it has been proposed that 
HCM sarcomere mutations may lead to increased energy 
cost of force generation through inefficient or excessive 
ATPase activity. This results in an energy deficiency of car-
diomyocytes that ultimately contributes to the pathogenesis 
of the disease (Ashrafian et al. 2003). Several studies support 
this pathogenic hypothesis (Jung et al. 1998; Crilley et al. 
2003; Javadpour et al. 2003; Chandra et al. 2005; He et al. 
2007; Luedde et al. 2009; Witjas-Paalberends et al. 2014b).
Investigations of the impact of some HCM-related muta-
tions on human cardiac myofibrils revealed a marked accel-
eration of the apparent rate with which force-generating CBs 
detach under isometric conditions (Belus et al. 2008; Ferran-
tini et al. 2009; Witjas-Paalberends et al. 2014a; Ferrantini 
et al. 2017; Piroddi et al. 2019; Vitale et al. 2019). These 
studies suggested that a primary mutation-driven effect 
on myofilaments can be an increase in tension cost. Direct 
measurement of ATPase activity in multicellular muscle 
strips from patients confirmed that the energy cost of isomet-
ric tension development was higher in HCM patients carry-
ing specific sarcomeric protein mutations compared to con-
trols and to HCM patients without an identified sarcomeric 
gene mutation  (HCMsmn, sarcomere mutation negative). This 
was true both for mutations of thick filament proteins, such 
as the R403Q myosin mutation, and for mutations of thin 
filament proteins, such as the K280N cardiac TnT mutation. 
While the marked impact of the R403Q mutation in myosin 
on CB kinetics and sarcomere energetics may be not surpris-
ing, the mechanisms of the effects of the K280N mutation 
in cTnT are much less clear. Pioneer studies, reviewed by 
Gordon et al. (2000), reported that HCM-associated cTnT 
mutations may cause changes in regulated acto-S1 ATPase 
and unloaded thin filament sliding speed. This implies that 
cTnT can modulate the CB kinetics of the strongly bound 
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Fig. 4  Relation between slow kREL and tension cost of different stri-
ated muscle preparations. There is a significant correlation (r = 0.90) 
between slow relaxation kinetics of myofibrils (15  °C) and the ten-
sion cost of larger permeabilized preparations (20  °C) from a vari-
ety of striated muscle tissues in spite of potential differences in the 
experimental conditions used in the different laboratories were the 
measurements were taken. Tension cost data of human atrial and 
ventricular preparations are from Narolska et  al. (2005); slow kREL 
data for the myofibrils from human atrial and ventricular samples are 
from Piroddi et al. (2007). Tension cost data of rabbit psoas (consist-
ent with earlier measurements), are from Joumaa et al. (2017); slow 
kREL data for the myofibrils from the same muscle are from Kreutz-
iger et al. (2008). Tension cost and slow kREL data for skinned mouse 
ventricular trabeculae and myofibrils are from Ferrantini et al. (2017). 
Tension cost and slow kREL data for skinned mouse atrial trabeculae 
and myofibrils are unpublished data from the Authors’ laboratory. All 
data are shown as mean ± SEM
 Journal of Muscle Research and Cell Motility
1 3
state in addition to its ability to control the attachment of 
CBs to the thin filament.
As shown in Fig. 5A, in all human HCM patient sam-
ples analyzed so far (three R403Q beta-MHC, one K280N 
cTnT, a few sarcomere mutation negative patients) it can be 
observed that slow kREL varies in proportion with the respec-
tive energy cost of tension development of each individual 
human cardiac sample independently from the protein car-
rying the mutation or even in the absence of any mutations 
(Fig. 5A). Data in Fig. 5A are replotted from published data 
(Witjas-Paalberends et al. 2014a; Piroddi et al. 2019).
An altered economy of muscle contraction associated to 
a faster rate of isometric relaxation in myofibrils was also 
found in an HCM mouse model carrying a mutation (E163R) 
of cTnT (Ferrantini et al. 2017). In the same study it was 
also shown that a second mouse model carrying a different 
mutation in the same protein (R92Q cTnT) did not exhibit 
the biophysical phenotype described above. As shown in 
Fig. 5B, a clear correlation between slow kREL and tension 
cost is maintained for all human and mouse models inves-
tigated independently from species, mutations, and disease 
states. The slope of the linear relation is relatively high and 
essentially the same as found in Fig. 5A. The same linear 
relation is maintained for changes in tension cost and slow 
kREL of one order of magnitude. Mouse data in Fig. 5B are 
from Ferrantini et al. (2017); human data are the same as 
in Fig. 5A with the individual data of the 3 R403Q patients 
replaced by the average data from all 3 patients.
Conclusions and implications
Overall, the data reviewed here provide evidence that a clear 
linear proportionality exists between the isometric apparent 
detachment rate of CBs (slow kREL) and the energetic cost 
of tension generation of the sarcomere measured in prepara-
tions from the same muscle sample. The relationship holds 
true among a variety of striated muscles from different 
species and also when CB kinetics is altered by sarcom-
eric mutations, strengthening the expectation of the simple 
two-state CB model (Brenner 1988) that the kinetics of CB 
detachment under isometric conditions along forward transi-
tions (g ~ slow kREL) correlates linearly with the amount of 
ATP spent per unit force.
The experimental observations that sarcomeric pro-
tein mutations associated to HCM are often associated to 
increased tension cost (Fig. 5) may, in principle, suffer from 
artifacts due to the structural remodeling often undergone 
by cardiac muscle in HCM. In fact, cardiomyocyte disarray 
may artificially decrease isometric tension and increase the 
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Fig. 5  Relation between slow kREL and tension cost in ventricular 
samples from human and mouse HCM models. All data are shown 
as mean ± SEM. A Data from human ventricular samples from differ-
ent HCM patients. The correlation between slow relaxation kinetics 
of human ventricular myofibrils (15  °C) and tension cost of human 
myocardial strips (20 °C) can be described by a line with slope 5.75 
(r = 0.99). Data from three patients carrying the R403Q mutation 
in β-myosin heavy chain [indicated as R403Q (1), (2), and (3)] and 
from HCM patients without an identified sarcomeric gene mutation 
(sarcomere mutation negative indicated as  HCMsmn) are from Witjas-
Paalberends et  al. 2014a. Data from the patient carrying a homozy-
gous mutation in cTnT (K280N) are from Piroddi et al. 2019. B Data 
from human and mouse models. The correlation between slow relaxa-
tion kinetics of ventricular myofibrils (15  °C) and tension cost of 
myocardial strips (20 °C) can be described by a line with slope 5.92 
(r = 0.99). Human data are the same as in panel A with the individual 
data of the 3 R403Q patients replaced by the average data from all 3 
patients. Mouse data are taken from Ferrantini et al. (2017). Indepen-
dently from species, mutations, and disesase state, slow kREL meas-
ured in myofibrils correlates linearly with the tension cost measured 
in multicellular muscle strips from the same samples
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“isometric” ATPase of multicellular preparations resulting in 
artificial increase in the tension cost. To address the problem 
we have developed techniques to reconstruct the 3D struc-
ture of the whole ventricular strips used for mechanical and 
energetic experiments (Vitale et al. 2019). Following 3D 
image reconstruction of the strips at sub-micrometer spatial 
resolution, cardiomyocyte orientation across and along the 
strips is determined. Statistics of spatial disarray are derived 
and correlated to mechanical and energetic data. Preliminary 
results (Vitale et al. 2019) do not highlight structural dif-
ferences between donor and HCM strips strengthening the 
conclusion that HCM mutations primarily alter apparent CB 
kinetics and impair sarcomere energetics.
Is the increase in the energy cost of isometric tension 
generation, observed with a number of HCM-associated 
mutations, expected to alter the overall cost of the actual 
cardiac cycle? Though our data do not say much about the 
energetic cost of contraction under mechanical conditions 
that are not isometric, the specific impact of a number of 
mutations associated to HCM on isometric CB kinetics 
and isometric tension cost may help explaining some yet 
unresolved clinical features of HCM. Generation of large 
amounts of isometric tension in the heart only occurs in the 
walls of the left ventricle (LV), especially during isovolumic 
contraction, though high tension is also maintained during 
LV ejection. Though the mutant proteins may be expressed 
in all cardiac chambers, the disease specifically affects the 
LV causing an asymmetric hypertrophy most often affect-
ing the interventricular septum. Theoretical models chal-
lenge the assumption of uniform myocardial wall tension 
in the LV contraction (DeAnda et al. 1998) and indicate the 
septum as the region where the highest stress is generated. 
This may be also supported by studies that show greater 
energy demands in the septum (Dunn 1984). Superimpos-
ing regional mechanical and metabolic differences on HCM 
myocytes might lead to localized uncompensated energetic 
load and hence asymmetric hypertrophy.
Does the increased energy cost of tension generation and 
the consequent energy impairment of HCM cardiomyocytes 
contribute to the asymmetric LV hypertrophy observed in 
HCM? Using magnetic resonance spectroscopy, a reduction 
in the cardiac PCr to ATP ratio, a measure of energetic sta-
tus, has been reported in HCM patients with LV hypertrophy 
(Crilley et al. 2003). In the same study, abnormal mean PCr/
ATP ratios have also been found in pre-hypertrophic carri-
ers of HCM mutations (genotype positive/clinical phenotype 
negative subjects) in which the energetic alterations cannot 
be attributed to the confounding hypertrophy. Therefore, it 
can be proposed that a primary stimulus for hypertrophy 
may be the energetic defect itself. If energy generation can-
not match demand, cytosolic  Ca2+ re-uptake/removal at 
the end of each contraction is compromised, particularly 
due to the extreme energy requirements of SERCA2, the 
sarcoplasmic reticulum  Ca2+ re-uptake pump. The resultant 
prolonged cytosolic  Ca2+ transient may be able to trigger 
downstream hypertrophy pathways.
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